rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2011-3-18
|
pubmed:abstractText |
To update the recommendations on the role of bone-modifying agents in the prevention and treatment of skeletal-related events (SREs) for patients with metastatic breast cancer with bone metastases.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1527-7755
|
pubmed:author |
pubmed-author:American Society of Clinical Oncology,
pubmed-author:BarlowWilliam EWE,
pubmed-author:BiermannJ SybilJS,
pubmed-author:BossermanLinda DLD,
pubmed-author:GeogheganCindyC,
pubmed-author:HillnerBruce EBE,
pubmed-author:JanjanNora ANA,
pubmed-author:TeminSarahS,
pubmed-author:TheriaultRichard LRL,
pubmed-author:Van PoznakCatherine HCH,
pubmed-author:Von RoennJamie HJH,
pubmed-author:YeeGary CGC,
pubmed-author:ZuckermanDan SDS
|
pubmed:issnType |
Electronic
|
pubmed:day |
20
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1221-7
|
pubmed:dateRevised |
2011-10-18
|
pubmed:meshHeading |
pubmed-meshheading:21343561-Antibodies, Monoclonal,
pubmed-meshheading:21343561-Bone Density Conservation Agents,
pubmed-meshheading:21343561-Bone Neoplasms,
pubmed-meshheading:21343561-Breast Neoplasms,
pubmed-meshheading:21343561-Diphosphonates,
pubmed-meshheading:21343561-Female,
pubmed-meshheading:21343561-Humans,
pubmed-meshheading:21343561-Imidazoles,
pubmed-meshheading:21343561-RANK Ligand,
pubmed-meshheading:21343561-Societies, Medical,
pubmed-meshheading:21343561-Survival Rate,
pubmed-meshheading:21343561-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer.
|
pubmed:affiliation |
University of Michigan, Ann Arbor, MI, USA.
|
pubmed:publicationType |
Journal Article,
Practice Guideline
|